Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie , DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels, 20.1.2022  
C(2022 ) 430 final  
PUBLIC VERSION  
APMH Invest A/S  
Esplanaden 50  
1263 Copenhagen  K 
Denmark  
Subject : Case M. 10585  – APMH INVEST / UNILABS  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 17 December 2021 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which  APMH  Invest 
A/S (“APMHI”, Denmark)  acquire s within the meaning of Article 3(1)(b) of the 
Merger Regulation  control of the whole of  Unilabs  Holding AB (“Unilabs”, 
Switzerland) by way of purchase of shares .3 
2. The business activities of the undertakings concerned are: 
 for APMHI: globally active investment company  controlled by A.P. Møller 
Holding A/S  (Denmark) , with investments in Maersk Tankers, Maersk Product 
Tankers, A.P. Moller Capital, KK Wind Solutions Holding A/S, Faerch, Nissens  
Cooling Solutions, Maersk Drilling, Danske Bank A/S and other financial 
investments in fixed income and securities. A.P. Møller Holding A/S  also controls 
A.P. Møller -Mærsk A/S, an integrated transport and logistics company with 
worldwide activities , 
 for U nilabs , controlled by Cidra GP S.à.r.l (Luxembourg) : provider of diagnostic 
services, which is active in the provision of bio -medical testing services (also 
known as CLTS), medical imaging services, reproductive medicine services and 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used  throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 523, 28.12.2021 , p. 8. 

2 drug development servi ces. Unilabs  has laboratories and/or imaging centres in 
several EU - and non -EU countries.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
paragr aph 5 (b) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agre ement . 
 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5 .